Cyclophosphamide Tablets IP
Malignant Disease :
Malignant lymphomas (Stages III and IV of the Ann Arbor staging system).
Non-Malignant Disease : Biopsy proven minimal change nephrotic syndrome in children
Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), Mixed-cell type lymphoma.
ADULTS AND CHILDREN :
General Oral Dosage : 400mg/m2 once daily for 5 days.
Dosage Adjustment :
Renal Impairment : Required
Hepatic Impairment : Not required
We are also dealing in:
|Name of the Product||Composition|
|Uniphos 1000||Cyclosphosphamide 1g|
|Uniphos 200||Cyclosphosphamide 200mg|
|Uniphos 500||Cyclosphosphamide 500mg|
|Uniphos 50mg||Cyclosphosphamide 50mg|